SCPH scPharmaceuticals
- 3.380
- -0.040-1.17%
scPharmaceuticals News
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(5.8%),Luther King Capital Management Corporation(5.5%)
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lundbeckfond Invest A/S (“Lundbeckfond”)(5.7%),Lene Skole (“Skole”)(5.7%)
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(5.9%)
scPharmaceuticals | 10-Q: Q3 2024 Earnings Report
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(4.6%),Luther King Capital Management Corporation(4.5%)
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D
scPharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Nokes Rachael
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
scPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%), etc.
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 10-Q: Q2 2024 Earnings Report
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 424B5: Prospectus
scPharmaceuticals | 424B5: Prospectus
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nokes Rachael
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)
scPharmaceuticals | 8-K: Current report
No Data